The long range objective of this project is to develop methods to modulate opioid peptide action through the peptidases which inactivate them. A major focus has been on the enzyme neprilysin (enkephalinase) which is involved in regulating extracellular enkephalin levels available for receptor binding. Studies will focus on the regulation of expression of multiple neprilysin mRNAs which differ in their 5' untranslated sequence, and are generated from different non-coding exons utilizing different promoters. Expression of neprilysin mRNAs in rat brain will be studied by in situ hybridization and compared to opiate receptor distribution. The effect of different 5' untranslated sequences on mRNA stability and translational efficiency will be determined to see if these factors contribute to the levels of neprilysin mRNA and enzyme activity in different cells. Transcriptional regulation of the neprilysin gene will be studied by comparing the promoter activity of fragments of the gene in cells expressing neprilysin compared to those that do not. Of particular interest will be regulatory elements upstream of the three non-coding exons, since these exons are expressed in a cell specific manner. A transgenic mouse model will be used to determine if cell specific elements identified by cell transfection analysis are functional in vivo Another phase of this project will be to study two newly identified peptidases from the EL-4 thymoma cell line; one cleaves dynorphin B to give Leu-enkephalin-Arg6, and the other cleaves Beta-endorphin to yield gamma-endorphin. These peptidases may be important in modulating opioid peptide actions through intracellular and/or extracellular processing. The cDNAs for these peptidases will be cloned. Specific antisera to each will be generated. These reagents will be used to determine the expression of these enzymes in various tissues and to determine their relationship to previously described enzymes with the same activity. The localization of these enzymes in secretory granules and their co- localization with reaction products will be examined. The mechanism of induction of the dynorphin B cleaving enzyme by morphine will be studied in EL-4 or SHS-Y5Y cells, focusing on whether this is translational or post-translational regulation. Specific inhibitors of the Beta-endorphin metabolizing enzyme will be generated and used to study the role of the enzyme on Beta-endorphin metabolism in brain slices. Attempts will be made to obtain the crystal structure of two peptidases acting on opioid peptides; the puromycin sensitive aminopeptidase and a bacterial neprilysin. High level expression of their cDNAs in E. coli will serve as a source of recombinant enzyme for crystallization trials.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA002243-22
Application #
2683803
Study Section
Special Emphasis Panel (SRCD (22))
Program Officer
Rapaka, Rao
Project Start
1978-09-30
Project End
2001-03-31
Budget Start
1998-06-01
Budget End
1999-03-31
Support Year
22
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Kentucky
Department
Biochemistry
Type
Schools of Medicine
DUNS #
832127323
City
Lexington
State
KY
Country
United States
Zip Code
40506
Song, Eun Suk; Ozbil, Mehmet; Zhang, Tingting et al. (2015) An Extended Polyanion Activation Surface in Insulin Degrading Enzyme. PLoS One 10:e0133114
Guan, Hanjun; Chow, K Martin; Song, Eunsuk et al. (2015) The Mitochondrial Peptidase Pitrilysin Degrades Islet Amyloid Polypeptide in Beta-Cells. PLoS One 10:e0133263
Sexton, Travis; Hitchcook, Lisa J; Rodgers, David W et al. (2012) Active site mutations change the cleavage specificity of neprilysin. PLoS One 7:e32343
Guan, H; Chow, K M; Shah, R et al. (2012) Degradation of islet amyloid polypeptide by neprilysin. Diabetologia 55:2989-98
Noinaj, Nicholas; Song, Eun Suk; Bhasin, Sonia et al. (2012) Anion activation site of insulin-degrading enzyme. J Biol Chem 287:48-57
Song, Eun Suk; Melikishvili, Manana; Fried, Michael G et al. (2012) Cysteine 904 is required for maximal insulin degrading enzyme activity and polyanion activation. PLoS One 7:e46790
Song, Eun Suk; Rodgers, David W; Hersh, Louis B (2011) Mixed dimers of insulin-degrading enzyme reveal a cis activation mechanism. J Biol Chem 286:13852-8
Chirra, Hariharasudhan D; Sexton, Travis; Biswal, Dipti et al. (2011) Catalase-coupled gold nanoparticles: comparison between the carbodiimide and biotin-streptavidin methods. Acta Biomater 7:2865-72
Noinaj, Nicholas; Bhasin, Sonia K; Song, Eun Suk et al. (2011) Identification of the allosteric regulatory site of insulysin. PLoS One 6:e20864
Shen, Xin-Ming; Crawford, Thomas O; Brengman, Joan et al. (2011) Functional consequences and structural interpretation of mutations of human choline acetyltransferase. Hum Mutat 32:1259-67

Showing the most recent 10 out of 96 publications